Xiaonan Han, PhD, a member of Case CCC's Cancer Genomics and Epigenomics Program, and collaborators have published a new study in Experimental & Molecular Medicine that advances understanding of how immune cells support intestinal stem cell regeneration during inflammation and tissue injury.
“Tetrameric STAT5 regulates the formation of immune niche cells to protect stem cell regenerative repair against mucosal inflammation” examines how STAT5 signaling regulates interactions between intestinal stem cells and specialized immune cells known as TCRγδ+ T cells within the intestinal crypt microenvironment.
Using patient biospecimens, mouse models, organoids, and single-cell sequencing approaches, investigators found that tetrameric STAT5 acts as a suppressor of crypt-associated immune niche formation. Disrupting this signaling pathway promoted expansion of TCRγδ+ T cells and enhanced intestinal stem cell regeneration following radiation injury and colitis.
Researchers also observed elevated crypt TCRγδ+STAT5+ T cells and reduced stem cell pluripotency signatures in ulcerative colitis patient samples, suggesting these immune-stem cell interactions may play an important role in mucosal repair during chronic inflammation. Mechanistic studies identified Metallothionein 1 (Mt1) as a regulator of T-cell migration into intestinal crypts.
While the study focused on inflammatory bowel disease, the findings have broader relevance to cancer biology by improving understanding of tissue regeneration, immune microenvironments, and recovery from treatment-related intestinal injury. The work may also inform future strategies to reduce gastrointestinal toxicity associated with radiation and other cancer therapies.